Resources › Videos & Animations

Videos & Animations

 
IMPERIAL Trial: FIrst of its Kind Design

IMPERIAL Trial: First of its Kind Design

Physicians provide an overview of the trial’s unique design, including the Eluvia DES and how investigators sought to improve on prior technologies.

 
Impact of the IMPERIAL Trial

Impact of the IMPERIAL Trial

Hear physician commentary on how the IMPERIAL Trial’s level 1 evidence is influencing their clinical and economic decisions.

 
IMPERIAL Trial: Influencing Treatment Algorithms

IMPERIAL Trial: Influencing Treatment Algorithms

See how IMPERIAL Trial results may help physicians make recommendations on which forms of antiproliferative therapies are best for each patient.

 
Video showing how the Eluvia Drug-Eluting Stent was designed to address the challenges of the SFA.

The Challenge

Hear what physicians have to say about the challenges of treating the SFA and how drug-eluting stents may help improve patient outcomes.

 
Eluvia Stent engineers finding the right formulation of paclitaxel and polymer for sustained drug release.

The Solution

Physicians talk about the importance of drug-eluting stents in complex lesions and how the Eluvia Drug-Eluting Stent is fine-tuned to produce a sustainable release of paclitaxel over time.

 
Video about the research and development process for the Eluvia Drug-Eluting Vascular Stent System.
 

The Heritage

See how over a decade of research helped Eluvia engineers develop the first drug-eluting stent for the SFA designed to sustain drug release when restenosis is most likely.

 
Stefan Müller-Hülsbeck, MD discusses the unprecedented clinical outcomes for the Eluvia Drug-Eluting Stent.

The Data

See what physicians are saying about the unprecedented clinical outcomes for the Eluvia Drug-Eluting Stent, including two-year primary patency and TLR rates.

 
Dr. William Gray discusses the sustained drug release of the Eluvia Drug-Eluting Vascular Stent System.

The Breakthrough

Physicians discuss the tuned paclitaxel elution profile of the Eluvia Drug-Eluting Stent and how the stent has demonstrated unprecedented efficacy data in patients with peripheral artery disease (PAD).

 
Dr. Jay Kokate discusses the challenges of treating the SFA.

The Challenges of the SFA

Find out how the challenging biological environment, mechanical issues and timing of disease progression impact treatment of the SFA.

 
Video showing how the Eluvia Drug-Eluting Stent was designed to help improve patient outcomes.

The Design of the Eluvia Drug-Eluting Stent System

Discover how the Eluvia Drug-Eluting Stent was designed to match the restenotic cascade for better healing and patency in the superficial femoral arteries (SFA).

Sign Up Today

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.

Top